These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Pyrolae herba alleviates cognitive impairment via hippocampal TREM2 signaling modulating neuroinflammation and neurogenesis in lipopolysaccharide-treated mice. Sun Y; Zhang H; Liu R; Huang R; Zhang X; Zhou S; Wu L; Zhu B; Wu H J Ethnopharmacol; 2024 Jan; 319(Pt 2):117214. PubMed ID: 37739108 [TBL] [Abstract][Full Text] [Related]
50. Role of TREM2 in Alzheimer's Disease: A Long Road Ahead. Kulkarni B; Kumar D; Cruz-Martins N; Sellamuthu S Mol Neurobiol; 2021 Oct; 58(10):5239-5252. PubMed ID: 34275100 [TBL] [Abstract][Full Text] [Related]
51. TREM2 regulates innate immunity in Alzheimer's disease. Li JT; Zhang Y J Neuroinflammation; 2018 Apr; 15(1):107. PubMed ID: 29655369 [TBL] [Abstract][Full Text] [Related]
52. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer's disease models. Fassler M; Rappaport MS; Cuño CB; George J J Neuroinflammation; 2021 Jan; 18(1):19. PubMed ID: 33422057 [TBL] [Abstract][Full Text] [Related]
53. Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients. Hu N; Tan MS; Yu JT; Sun L; Tan L; Wang YL; Jiang T; Tan L J Alzheimers Dis; 2014; 38(3):497-501. PubMed ID: 24002183 [TBL] [Abstract][Full Text] [Related]
54. TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia. Mori Y; Yoshino Y; Ochi S; Yamazaki K; Kawabe K; Abe M; Kitano T; Ozaki Y; Yoshida T; Numata S; Mori T; Iga J; Kuroda N; Ohmori T; Ueno S PLoS One; 2015; 10(9):e0136835. PubMed ID: 26332043 [TBL] [Abstract][Full Text] [Related]
55. Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention. Engelman CD; Koscik RL; Jonaitis EM; Hermann BP; La Rue A; Sager MA Neurobiol Aging; 2014 Jun; 35(6):1252-4. PubMed ID: 24378087 [TBL] [Abstract][Full Text] [Related]
56. Efficacy and mechanism of cGAMP to suppress Alzheimer's disease by elevating TREM2. Xu Q; Xu W; Cheng H; Yuan H; Tan X Brain Behav Immun; 2019 Oct; 81():495-508. PubMed ID: 31283973 [TBL] [Abstract][Full Text] [Related]
57. A natural small molecule aspidosperma-type alkaloid, hecubine, as a new TREM2 activator for alleviating lipopolysaccharide-induced neuroinflammation in vitro and in vivo. Li L; He YL; Xu N; Wang XF; Song B; Tang BQ; Lee SM Redox Biol; 2024 Apr; 70():103057. PubMed ID: 38325196 [TBL] [Abstract][Full Text] [Related]
58. TREM2 and the neuroimmunology of Alzheimer's disease. Hickman SE; El Khoury J Biochem Pharmacol; 2014 Apr; 88(4):495-8. PubMed ID: 24355566 [TBL] [Abstract][Full Text] [Related]
59. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease. Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597 [TBL] [Abstract][Full Text] [Related]
60. The role of TREM2 in Alzheimer's disease: from the perspective of Tau. Huang W; Huang J; Huang N; Luo Y Front Cell Dev Biol; 2023; 11():1280257. PubMed ID: 38020891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]